Literature DB >> 25697270

The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives.

Parham Taslimi1, Ilhami Gulcin1,2, Bunyamin Ozgeris1, Suleyman Goksu1, Ferhan Tumer3, Saleh H Alwasel2, Claudiu T Supuran4,5.   

Abstract

Carbonic anhydrases (CAs, EC 4.2.1.1) had six genetically distinct families described to date in various organisms. There are 16 known CA isoforms in humans. Human CA isoenzymes I and II (hCA I and hCA II) are ubiquitous cytosolic isoforms. Acetylcholine esterase (AChE. EC 3.1.1.7) is a hydrolase that hydrolyzes the neurotransmitter acetylcholine relaying the signal from the nerve. In this study, some trimethoxyindane derivatives were investigated as inhibitors against the cytosolic hCA I and II isoenzymes, and AChE enzyme. Both hCA isozymes were inhibited by trimethoxyindane derivatives in the low nanomolar range. These compounds were good hCA I inhibitors (Kis in the range of 1.66-4.14 nM) and hCA II inhibitors (Kis of 1.37-3.12 nM) and perfect AChE inhibitors (Kis in the range of 1.87-7.53 nM) compared to acetazolamide as CA inhibitor (Ki: 6.76 nM for hCA I and Ki: 5.85 nM for hCA II) and Tacrine as AChE inhibitor (Ki: 7.64 nM).

Entities:  

Keywords:  Acetylcholine esterase; affinity chromatography carbonic anhydrase; enzyme inhibition; enzyme purification; trimethoxyindane derivatives

Mesh:

Substances:

Year:  2015        PMID: 25697270     DOI: 10.3109/14756366.2015.1014476

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  5 in total

1.  Discovery of Potent Carbonic Anhydrase and Acetylcholinesterase Inhibitors: 2-Aminoindan β-Lactam Derivatives.

Authors:  Hayriye Genç; Ramazan Kalin; Zeynep Köksal; Nastaran Sadeghian; Umit M Kocyigit; Mustafa Zengin; İlhami Gülçin; Hasan Özdemir
Journal:  Int J Mol Sci       Date:  2016-10-20       Impact factor: 5.923

2.  Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides.

Authors:  Halise Inci Gul; Ebru Mete; Sakip Emre Eren; Hiroshi Sakagami; Cem Yamali; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-23       Impact factor: 5.051

3.  Synthesis and bioactivity of several new hetaryl sulfonamides.

Authors:  Parham Taslimi; Afsun Sujayev; Sevgi Mamedova; Pınar Kalın; İlhami Gulçin; Nastaran Sadeghian; Sukru Beydemir; O Irfan Kufrevioglu; Saleh H Alwasel; Vagif Farzaliyev; Sabir Mamedov
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

4.  Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors.

Authors:  Moataz Shaldam; Alessio Nocentini; Zainab M Elsayed; Tamer M Ibrahim; Rofaida Salem; Ramadan A El-Domany; Clemente Capasso; Claudiu T Supuran; Wagdy M Eldehna
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

5.  Synthesis, Carbonic Anhydrase II/IX/XII Inhibition, DFT, and Molecular Docking Studies of Hydrazide-Sulfonamide Hybrids of 4-Methylsalicyl- and Acyl-Substituted Hydrazide.

Authors:  Adil Khushal; Amara Mumtaz; Wamda Ahmed Shadoul; Syeda Huda Mehdi Zaidi; Hummera Rafique; Abida Munir; Aneela Maalik; Syed Jawad Ali Shah; Ayesha Baig; Wajiha Khawaja; Mariya Al-Rashida; Muhammad Ali Hashmi; Jamshed Iqbal
Journal:  Biomed Res Int       Date:  2022-02-24       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.